Biochemical and Biophysical Research Communications
Amyloid formation and disaggregation of α-synuclein and its tandem repeat (α-TR)
Research highlights
► Formation of the α-synuclein amyloid fibrils by [BIMbF3Im]. ► Disaggregation of amyloid fibrils by epigallocatechin gallate (EGCG) and baicalein. ► Amyloid formation of α-synuclein tandem repeat (α-TR).
Introduction
Parkinson’s disease (PD) is characterized by degeneration of dopaminergic neurons in the substantia nigra and by deposits of cytoplasmic inclusions (Lewy bodies). α-Synuclein, which is involved in neuronal plasticity, stabilization of lipid membranes, neurotransmitter release, and protein networks, is the major building block of the pathological fibrillar deposits within Lewy bodies [1], [2], [3]. α-Synuclein is a small (14 kDa) low-structured protein, possessing several imperfect KTKEGV repeats in the N-terminal portion (a.a. 1–95), and an highly acidic C-terminal portion (a.a. 96–140). Specifically, the central region (a.a. 61–95) is the core region that is mainly responsible for fibril formation. For example, the alterations of several hydrophobic amino acids in this region can significantly change the polymerization into amyloid [4], [5], [6]. Using several biophysical techniques, α-synuclein was shown to undergo conformational changes from its low-structured native state to the highly crossed β sheet-rich conformation of amyloid fibrils [7], [8], [9]. Additionally, the conversion of soluble α-synuclein into insoluble aggregates is believed to be a key event in the pathogenesis of PD and related diseases. Interestingly, in contrast to α-synuclein, β- and γ-synuclein, which are not related to neurodegenerative diseases, cannot readily form amyloid fibrils in vitro [6], [8]. Therefore, a comprehensive understanding of the mechanism of amyloid fibril formation at the molecular level is very important to elucidate the pathogenesis of PD and for the development of clinical treatment and diagnostic tools.
Although increasing evidences suggest that a prefibrillar intermediate, not amyloid fibril, is mainly responsible for neuronal cell death, the nature of the neurotoxic species and its mode of action still remain largely unknown. To date, therapeutic strategies are mainly focused on the inhibition of the amyloid formation process, as early as its initial stage, by using organic molecules, heat shock proteins and antibodies [10], [11], [12]. Here, we suggest alternative strategies which avoid cytotoxic intermediates by using ionic liquids (ILs) that could stabilize the formation of amyloid fibrils [13], [14]. As a first step, we have investigated the interaction of α-synuclein with ionic liquids, using several biochemical techniques, including Thioflavin T assays and transmission electron microscopy (TEM). We showed a rapid formation of α-synuclein amyloid fibrils stimulated by 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide [BIMbF3Im]. Furthermore, the effect of [BIMbF3Im] on the α-synuclein tandem repeat (α-TR) in the aggregation process was studied. Our data shows that these fibrils could be disaggregated by the polyphenols such as epigallocatechin gallate (EGCG) and baicalein. Therefore, use of ionic liquids such as [BIMbF3Im] could represent an alternative strategy for attacking neurodegenerative diseases. Considering the enormous chemical variability of ionic liquids, this study will encourage further investigations on the effects of ionic liquids on the neurodegenerative diseases such as Parkinson’s disease (PD).
Section snippets
Expression and purification of α-synuclein and its related proteins
Wild type α-, β-, and γ-synuclein were expressed and purified as previously described [7]. γ-synuclein plasmid was a kind gift from Dr. J. Liu (Department of Veterans Affairs, Palo Alto Health Care System, USA.). For α-synuclein tandem repeat (α-TR), codon optimization of the complete ORF (840 bp) of the gene sequence was performed, which was then commercially synthesized (Genscript Corp., Piscataway, NJ). The synthesized α-TR gene was cloned into pET-21a using NdeI and HindIII restriction sites
Results
Abnormal aggregation of α-synuclein is clearly related to the etiology of Parkinson’s diseases (PD) and current studies are mainly focused on the suppression or inhibition of the formation of cytotoxic intermediates [2], [5], [8]. In a previous report, we have shown that ionic liquids could assist and stabilize the fibril formation process of α-synuclein [13]. Here, we examined the effects of two representative ionic liquids, 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide [BIMbF3
Discussion
Amyloid deposits of α-synuclein are clearly linked to the pathogenesis of Parkinson’s disease (PD), but little information is known concerning the nucleation steps and cytotoxic forms of α-synuclein. Recent studies suggest that α-synuclein protofibrillar intermediates, not amyloid fibrils, are the pathogenic species in neuronal cell death and neurodegeneration [2], [3], [23], [24]. Therefore, inhibition or suppression of cytotoxic intermediates, as early as its nucleation steps, is highly
Acknowledgments
This work was supported by a Korean Research Foundation Grant funded by the Korean Government (KRF-2009-0089832) and by a 2008 Ajou University research fellowship to T.D.K. S.L. was supported through the Chronic Inflammatory Disease Research Center at Ajou University (KOSEF-R13-2003-019).
References (29)
- et al.
Molecular mechanisms of alpha-synuclein neurodegeneration
Biochim. Biophys. Acta
(2009) Molecular and cellular biology of synucleins
Int. Rev. Cell. Mol. Biol.
(2008)- et al.
Ionic liquids promote amyloid formation from alpha-synuclein
Anal. Biochem.
(2009) - et al.
Identification and characterization of a novel (S)-ketoprofen-specific esterase
Int. J. Biol. Macromol.
(2007) - et al.
The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils
J. Biol. Chem.
(2004) - et al.
Aalpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson’s disease
J. Biol. Chem.
(1999) - et al.
Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention
Exp. Neurol.
(2010) - et al.
Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein
J. Mol. Biol.
(2008) - et al.
Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity
J. Biol. Chem.
(2004) - et al.
A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids
Bioorg. Med. Chem. Lett.
(2010)
Structural insights on physiological functions and pathological effects of alpha-synuclein
FASEB J.
Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
Nat. Genet.
Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization
Biochemistry
Alpha-synuclein aggregation
Protein Pept. Lett.
Cited by (33)
Modulating α-synuclein fibril formation using DNA tetrahedron nanostructures
2019, Biochimica et Biophysica Acta - General SubjectsCitation Excerpt :As shown in Fig. 2A, buffer as well as Td55 only exhibited insignificant fluorescence intensity. The aggregation kinetics of α-syn in the absence of Td55 were observed to be in good agreement with our previously reported kinetic measurements of α-syn under similar incubation conditions [29,35,36]. However, a significant increase in ThT fluorescence intensity was observed after incubating α-syn in the presence of Td55 at 37 °C for 7 days, indicating strong accelerations of ɑ-syn amyloid fibril formation (Fig. 2A and S1).
Protein folding, misfolding and aggregation: A tale of constructive to destructive assembly
2018, International Journal of Biological MacromoleculesCitation Excerpt :Levodopa, precursor of dopamine, inhibits HSA fibrillation by stabilizing the nearby amino acid residues of drug binding site and also disaggregates pre-formed amyloids [163]. Epigallocatechin gallate (EGCG) and baicaleinmediate the disaggregation of α-synuclein fibrils induced by 1-butyl-3-methylimidazolium bis (trifluoromethylsulfonyl) imide [BIMbF3Im] [164]. Cyclophilins (Cyps) of L. donovani origin known as (LdCyp) shows diverse action depending on the protein as it disaggregate insoluble aggregate of adenosine kinase (AdK) but also can induce fibrils of lysozyme on co-incubation [165].
Parkinson's Disease
2018, Integrative Medicine: Fourth EditionIdentification, characterization, immobilization, and mutational analysis of a novel acetylesterase with industrial potential (LaAcE) from Lactobacillus acidophilus
2018, Biochimica et Biophysica Acta - General SubjectsBiocompatibility of ionic liquids towards protein stability: A comprehensive overview on the current understanding and their implications
2017, International Journal of Biological MacromoleculesCitation Excerpt :Even though, a few of the literature are still scattered (and sometimes difficult to explore from the ocean of science) that deal with the stability of biologically important proteins in the presence of ILs. Hence, in this section, we have tried to gather all these research reports [382–417] under the same roof, so that it is easily available to the readers and also to expose its importance to the scientific world. An overview of the literature reveals stability studies of proteins such as, amyloglucosidase [382], thyroglobulin [382], glutamate dehydrogenase [382], lactate dehydrogenase [382], glucose dehydrogenase [383], formate dehydrogenase [397], insulin [11], glycosidase (α and β) [384], monellin [385], β-galactosidase [386], glucose oxidase [409], lactate oxidase [412], oxidoreductases [410], subtilisin Carlsberg [387], Amano protease P6 [388], pepsin [389], papain [390,403], esterases from Bacillus subtilis and Bacillus stearothermophilus[390], Penicillium expansum lipase [391], mushroom tyrosinase [391], chloroperoxidase [392], porcine pancreatic lipase [394], α-helical protein Im7 [395], pepsin [396], adenosine deaminase [398], α-amylases [399], xylanase II (GH11 enzyme, from Trichoderma longibrachiatum [400], lactoferrin [402], α-synuclein [404,406], ribonuclease A [405], casein [407,408], epoxide hydrolase [413], avidin [414], Abeta (1–40) peptide [415], zein [416] and Firefly luciferase (Photinus pyralisluciferase) in the ILs.
Inhibitory effect of copper nanoparticles on rosin modified surfactant induced aggregation of lysozyme
2015, International Journal of Biological MacromoleculesCitation Excerpt :Surfactants play an important role in protein chemistry, protein surfactant interaction, protein unfolding and denaturation by inducing conformational alterations in the secondary and tertiary structures of the protein [4,28]. Surfactants may either induce or inhibit the aggregation process which depends on the associated conditions [29–40]. Due to ever increasing therapeutic role of nanoparticles (NPs) we have chosen copper (Cu), silver (Ag) and zinc (Zn) NPs to investigate their effects on QRMAE-induced lysozyme aggregation.
- 1
Present address: Science Education Division, Korea Institute for Curriculum and Evaluation.